PRESS RELEASE published on 05/30/2023 at 13:00, 1 year 5 months ago Eckert & Ziegler to Host First Radionuclide Theranostics Forum in Boston, MA
PRESS RELEASE published on 05/15/2023 at 09:27, 1 year 6 months ago Reorganization in the Executive Board of Eckert & Ziegler
PRESS RELEASE published on 05/11/2023 at 07:45, 1 year 6 months ago Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
PRESS RELEASE published on 05/08/2023 at 11:15, 1 year 6 months ago Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
PRESS RELEASE published on 04/25/2023 at 17:59, 1 year 6 months ago EQS-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2023 with Double-digit Sales Growth, Earnings Decline and Confirmation of 2023 Full-Year Guidance
PRESS RELEASE published on 04/20/2023 at 10:00, 1 year 7 months ago Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177
PRESS RELEASE published on 04/12/2023 at 15:00, 1 year 7 months ago Eckert & Ziegler Receives Environmental Approval for Jintan Radioisotope Site
PRESS RELEASE published on 04/04/2023 at 14:00, 1 year 7 months ago Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
PRESS RELEASE published on 03/30/2023 at 07:45, 1 year 7 months ago Eckert & Ziegler: Successful fiscal year 2022
PRESS RELEASE published on 03/24/2023 at 16:40, 1 year 7 months ago Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
Published on 11/21/2024 at 22:05, 1 hour 29 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 1 hour 44 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 19 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 3 hours 24 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 3 hours 34 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:01, 4 hours 33 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 4 hours 58 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 5 hours 35 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 5 hours 42 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 5 hours 42 minutes ago LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Published on 11/21/2024 at 06:58, 16 hours 36 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 16 hours 36 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 16 hours 36 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 3 hours ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
